Swisse Nutra+

Swisse Nutra+ | Joint Pain Complex

Swisse Nutra+ | Joint Pain Complex
Swisse Nutra+ | Joint Pain Complex
Select Size / Option
AUD
Buy 2+: 42.46 ea
Buy 4+: 39.96 ea
Please select the quantity
Visa, Mastercard, Amex, Wechat Pay, PayPal, Alipay

Also found in: Anti Inflammatory

Swisse Nutra+ Joint Pain Complex Read more

Worldwide Shipping Available ✈ Calculated at shopping cart Info >

Product Description

Swisse Nutra+ | Joint Pain Complex

Swisse Nutra+ Joint Pain Complex is scientifically formulated with 5-Loxin™ Boswellia serrata, a specialised ingredient that may help relieve inflammation and symptoms of mild osteoarthritis such as mild joint pain and soreness.

 

Ingredients

 

EACH TABLET CONTAINS:

 

5-Loxin™ (Boswellia serrata extract)

     equiv. dry gum 1 g

50 mg

NEM® (Egg shell membrane powder)

250 mg


ALLERGEN INFORMATION:
No added lactose, gluten, yeast, artificial colours or flavours. Contains egg, soya beans & sulfites.

 

Cautions

  • This medicine may not be right for you.
  • Read the label before purchase.
  • Follow the directions for use.
  • If symptoms persist, talk to your health professional.
  • Supplements may only be of assistance if dietary intake is inadequate.

 

Storage

Store below 25°C in a cool, dry place. Do not use if cap seal is broken.

 

For the most up to date information on this product, please visit the brand / manufacturer website as product descriptions and directions can change.

Practitioner Form

This is a practitioner-only brand. As a requirement from this company you are required to answer the questions below. Once answered you can proceed to purchase and place your order.
One of our health care practitioners will review this information and may contact you if further information is required.

Are you pregnant or breastfeeding?


Do you have any diagnosed allergies or have had an allergic reaction before?


Do you have any underlying health conditions/disease?


Do you take any other medicines?


Are you taking this supplement under the current guidance of a practitioner?